Bronsteatter named director of Wound & Hyperbarics
For the Rapids City Times
WISCONSIN RAPIDS – Loretta Bronsteatter has been named Director of Aspirus Riverview Wound & Hyperbarics.
In her new position, Bronsteatter is responsible for all aspects of the center’s operation, including ensuring quality patient care, recruitment and hiring, compliance with federal and state guidelines, budgeting and fiscal policies, and marketing and sales.
Bronsteatter holds a bachelor of science degree in sociology and a master of science degree in psychology. Prior to joining Aspirus Riverview Wound & Hyperbarics, she served in leadership positions in patient experience improvement, clinical and business operations, physician practice management, program marketing and development, and metric and analytics consulting.
Located within Aspirus Riverview Hospital at 410 Dewey Street, Aspirus Riverview Wound & Hyperbarics offers highly specialized wound care to patients suffering from diabetic ulcers, pressure ulcers, infections, and other chronic wounds that have not healed in a reasonable amount of time.
With a success rate of healing 95 percent of wounds within 26 days, Aspirus Riverview Wound & Hyperbarics uses advanced treatments including negative pressure wound therapy, bio-engineered skin substitutes, hyperbaric oxygen therapy, biological and biosynthetic dressings, and growth factor therapies. Aspirus Riverview Wound & Hyperbarics is a partner of Healogics, the nation’s largest provider of advanced wound care services.
To learn more about Aspirus Riverview Wound & Hyperbarics, call 715-422-7755 or visit aspirus.org/RiverviewWoundCenter.